Published in J Virol on October 01, 1994
p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol (1995) 6.87
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol (2012) 5.71
Viral late domains. J Virol (2002) 4.51
Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog (2008) 3.27
Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J Virol (1995) 2.88
Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM). EMBO J (1996) 2.84
Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. J Virol (2008) 2.41
A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe (2009) 2.34
Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol (1996) 2.33
Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J Virol (1995) 2.09
Human immunodeficiency virus type 1 modified to package Simian immunodeficiency virus Vpx efficiently infects macrophages and dendritic cells. J Virol (2011) 1.85
Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J Virol (1999) 1.79
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77
Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr? Retrovirology (2010) 1.76
Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J Virol (1997) 1.65
A conserved dileucine-containing motif in p6(gag) governs the particle association of Vpx and Vpr of simian immunodeficiency viruses SIV(mac) and SIV(agm). J Virol (1999) 1.60
A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr. J Virol (1996) 1.47
Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology (2011) 1.32
The C-terminal proline-rich tail of human immunodeficiency virus type 2 Vpx is necessary for nuclear localization of the viral preintegration complex in nondividing cells. J Virol (2000) 1.29
Functional analysis of the simian immunodeficiency virus Vpx protein: identification of packaging determinants and a novel nuclear targeting domain. J Virol (2001) 1.20
Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly. J Virol (1998) 1.20
Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein. J Virol (1997) 1.01
Vpr of simian immunodeficiency virus of African green monkeys is required for replication in macaque macrophages and lymphocytes. J Virol (1997) 0.96
Identification of critical regions in human SAMHD1 required for nuclear localization and Vpx-mediated degradation. PLoS One (2013) 0.96
Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles. J Virol (1996) 0.96
Efficient transduction of myeloid cells by an HIV-1-derived lentiviral vector that packages the Vpx accessory protein. Gene Ther (2012) 0.95
Human immunodeficiency virus type 2 Vpx-Gag interaction. J Virol (1998) 0.95
Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo. J Virol (2004) 0.91
New insights into an X-traordinary viral protein. Front Microbiol (2014) 0.90
Interaction of human immunodeficiency virus type 2 Vpx and invariant chain. J Virol (2000) 0.85
Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells. Retrovirology (2012) 0.84
Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins. J Virol (2013) 0.82
Nonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport. PLoS One (2014) 0.78
Degradation of SAMHD1 by Vpx Is Independent of Uncoating. J Virol (2015) 0.76
Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly. J Virol (2017) 0.75
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 32.58
Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (1987) 11.79
Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell (1989) 9.68
Form, function, and use of retroviral gag proteins. AIDS (1991) 9.24
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J Virol (1990) 7.90
Complete nucleotide sequences of functional clones of the AIDS virus. AIDS Res Hum Retroviruses (1987) 7.85
Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes. Mol Cell Biol (1987) 6.13
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol (1989) 6.11
Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J Virol (1990) 5.45
Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol (1993) 5.30
Identification of HIV-1 vpr product and function. J Acquir Immune Defic Syndr (1990) 4.35
Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J Virol (1990) 4.35
Human immunodeficiency virus-like particles produced by a vaccinia virus expression vector. Proc Natl Acad Sci U S A (1989) 4.26
Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol (1993) 4.16
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50
Mutational analysis of the human immunodeficiency virus vpr open reading frame. J Virol (1989) 3.48
A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J Virol (1990) 3.33
Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J (1992) 3.25
Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. J Gen Virol (1992) 2.89
Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J Virol (1992) 2.86
Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne). J Virol (1988) 2.76
Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2. Science (1988) 2.76
Human immunodeficiency virus vpr gene encodes a virion-associated protein. AIDS Res Hum Retroviruses (1990) 2.67
VPX mutants of HIV-2 are infectious in established cell lines but display a severe defect in peripheral blood lymphocytes. EMBO J (1989) 2.45
RNA packaging signal of human immunodeficiency virus type 1. Virology (1992) 2.38
A naturally immunogenic virion-associated protein specific for HIV-2 and SIV. Nature (1988) 2.33
Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology (1990) 2.24
Requirement of the Pr55gag precursor for incorporation of the Vpr product into human immunodeficiency virus type 1 viral particles. J Virol (1994) 2.20
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J Virol (1990) 1.86
Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology (1993) 1.75
Origin of vpx in lentiviruses. Nature (1990) 1.73
Identification of a novel retroviral gene unique to human immunodeficiency virus type 2 and simian immunodeficiency virus SIVMAC. J Virol (1988) 1.66
Human immunodeficiency virus type 2 vpx protein augments viral infectivity. Virology (1991) 1.65
Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions. J Virol (1993) 1.36
Centrophilin: a novel mitotic spindle protein involved in microtubule nucleation. J Cell Biol (1991) 1.36
HIV-2 viral protein X association with the GAG p27 capsid protein. Virology (1994) 1.35
Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication. J Virol (1991) 1.31
Monoclonal antibodies against human immunodeficiency virus (HIV) type 2 core proteins: cross-reactivity with HIV type 1 and simian immunodeficiency virus. Proc Natl Acad Sci U S A (1988) 1.16
A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1993) 1.13
Analysis of retroviral assembly using a vaccinia/T7-polymerase complementation system. Virology (1993) 1.06
Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir. J Gen Virol (1986) 1.06
Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31
High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science (1993) 12.22
Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc Natl Acad Sci U S A (1994) 8.06
Real-time prediction of hand trajectory by ensembles of cortical neurons in primates. Nature (2000) 7.29
High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med (1991) 7.01
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol (2000) 6.71
A novel family of divergent seven-transmembrane proteins: candidate odorant receptors in Drosophila. Neuron (1999) 6.03
Apg9p/Cvt7p is an integral membrane protein required for transport vesicle formation in the Cvt and autophagy pathways. J Cell Biol (2000) 4.30
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22
The itinerary of a vesicle component, Aut7p/Cvt5p, terminates in the yeast vacuole via the autophagy/Cvt pathways. J Biol Chem (2000) 3.97
Identification of a novel bacterial sequence associated with Crohn's disease. Gastroenterology (2000) 3.90
Dissection of autophagosome biogenesis into distinct nucleation and expansion steps. J Cell Biol (2000) 3.64
Human chromosome 19 and related regions in mouse: conservative and lineage-specific evolution. Science (2001) 3.39
Calmodulin target database. J Struct Funct Genomics (2000) 3.20
Cvt19 is a receptor for the cytoplasm-to-vacuole targeting pathway. Mol Cell (2001) 3.12
Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes. EMBO J (1999) 3.11
Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J Clin Microbiol (1999) 3.04
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med (1993) 2.98
Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis (2002) 2.92
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial. Lancet (2001) 2.85
Soft tissue cephalometric analysis: diagnosis and treatment planning of dentofacial deformity. Am J Orthod Dentofacial Orthop (1999) 2.81
Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science (1993) 2.78
Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol (R Coll Radiol) (2007) 2.67
Surface attachment of Salmonella typhimurium to intestinal epithelia imprints the subepithelial matrix with gradients chemotactic for neutrophils. J Cell Biol (1995) 2.53
Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology (2009) 2.47
Measurement in vivo of proliferation rates of slow turnover cells by 2H2O labeling of the deoxyribose moiety of DNA. Proc Natl Acad Sci U S A (2002) 2.46
Distinct functional phenotypes of cloned Ia-restricted helper T cells. J Exp Med (1985) 2.39
Design of biomimetic fibrillar interfaces: 1. Making contact. J R Soc Interface (2004) 2.38
Electron microscope studies of heteroduplex DNA from a deletion mutant of bacteriophage phiX-174. Proc Natl Acad Sci U S A (1972) 2.29
The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J Virol (1995) 2.25
Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc Natl Acad Sci U S A (1995) 2.24
Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO J (1997) 2.23
Ultrabithorax regulates genes at several levels of the wing-patterning hierarchy to shape the development of the Drosophila haltere. Genes Dev (1998) 2.22
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer (2008) 2.21
A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. Proc Natl Acad Sci U S A (1995) 2.20
Human immunodeficiency virus type 1 integrase protein promotes reverse transcription through specific interactions with the nucleoprotein reverse transcription complex. J Virol (1999) 2.16
Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature (2000) 2.13
Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains. Proc Natl Acad Sci U S A (1997) 2.11
An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy (2004) 2.10
Unique and shared functions of different connexins in mice. Curr Biol (2000) 2.10
Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol (1997) 2.10
Stroke mechanism in patients with non-valvular atrial fibrillation according to the CHADS2 and CHA2 DS2 -VASc scores. Eur J Neurol (2011) 2.09
Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. J Am Coll Cardiol (1999) 2.09
Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. Circulation (1997) 2.06
Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol (2002) 2.05
Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect (2007) 2.00
An outbreak of Campylobacter jejuni infections associated with food handler contamination: the use of pulsed-field gel electrophoresis. J Infect Dis (2000) 1.99
Apg2 is a novel protein required for the cytoplasm to vacuole targeting, autophagy, and pexophagy pathways. J Biol Chem (2001) 1.99
The Vestigial and Scalloped proteins act together to directly regulate wing-specific gene expression in Drosophila. Genes Dev (1998) 1.99
Vascular and metabolic response to isolated small muscle mass exercise: effect of age. Am J Physiol Heart Circ Physiol (2003) 1.97
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol Biol Cell (1993) 1.97
Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology (1993) 1.92
Assembly of an A kinase-anchoring protein-beta(2)-adrenergic receptor complex facilitates receptor phosphorylation and signaling. Curr Biol (2000) 1.90
Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate. J Virol (1990) 1.86
West African HIV-2-related human retrovirus with attenuated cytopathicity. Science (1988) 1.86
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86
Correlated errors in biased surrogates: study designs and methods for measurement error correction. Stat Med (2005) 1.85
The regulation of AMP-activated protein kinase by H(2)O(2). Biochem Biophys Res Commun (2001) 1.84
Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. J Exp Med (1993) 1.81
Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother (2001) 1.81
Mutational analysis of the hepatitis C virus RNA helicase. J Virol (1997) 1.77
Targeting foreign proteins to human immunodeficiency virus particles via fusion with Vpr and Vpx. J Virol (1995) 1.77
Visual and instrumental colorimetric assessments of small color differences on translucent dental porcelain. J Dent Res (1989) 1.77
Degradation of lipid vesicles in the yeast vacuole requires function of Cvt17, a putative lipase. J Biol Chem (2000) 1.75
Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components. Virology (1993) 1.75
The nitrogenase FeMo-cofactor and P-cluster pair: 2.2 A resolution structures. Science (1993) 1.74
Results of transvenous embolization of cavernous dural arteriovenous fistula: a single-center experience with emphasis on complications and management. AJNR Am J Neuroradiol (2006) 1.73
Electrical conduction through poly(dA)-poly(dT) and poly(dG)-poly(dC) DNA molecules. Phys Rev Lett (2001) 1.72
Evidence for autoregulation of cystathionine gamma-synthase mRNA stability in Arabidopsis. Science (1999) 1.72
Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry (1997) 1.68
Physician fees and procedure intensity: the case of cesarean delivery. J Health Econ (1999) 1.68
Multiple sets of basal factors initiate transcription by RNA polymerase II. J Biol Chem (1994) 1.68
Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol (2001) 1.68
Vascular and metabolic response to cycle exercise in sedentary humans: effect of age. Am J Physiol Heart Circ Physiol (2002) 1.67
Activation of the TFIID-TFIIA complex with HMG-2. Genes Dev (1995) 1.66
Structure and chromosomal location of the gene for endothelial-leukocyte adhesion molecule 1. J Biol Chem (1991) 1.66
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis. Urology (2001) 1.65
Head taps evoke a crossed vestibulo-ocular reflex. Neurology (2007) 1.65
Human immunodeficiency virus type 2 vpx protein augments viral infectivity. Virology (1991) 1.65
Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology (2000) 1.63
New proteins related to the Ser-Arg family of splicing factors. RNA (1995) 1.62
Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. JAMA (2000) 1.62
DNA bending by negative regulatory proteins: Gal and Lac repressors. Genes Dev (1989) 1.62
Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J Immunol (1996) 1.59
Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest (1994) 1.58
Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer (2010) 1.57
Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: a prospective study. Circulation (1997) 1.55
Prophylaxis against the systemic hypotension induced by propofol during rapid-sequence intubation. Can J Anaesth (1995) 1.52
UV irradiation and heat shock mediate JNK activation via alternate pathways. J Biol Chem (1995) 1.51
S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy. Ann Oncol (2014) 1.51